Bnp Paribas Asset Management Holding S.A. Arcutis Biotherapeutics, Inc. Call Options Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARQT
# of Institutions
247Shares Held
131MCall Options Held
407KPut Options Held
216K-
Jennison Associates LLC12.3MShares$256 Million0.14% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.5MShares$241 Million5.56% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$224 Million3.47% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.87MShares$206 Million7.3% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$180 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $1.26B
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...